相关实验视频

Updated: May 31, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.5K

梅特福林摄入量和尿路转移的激进囊切除术后代谢酸的风险:使用TriNetX研究网络数据进行的一项比较研究

Maximilian Pallauf1, Stephan Brönimann2, Michael E Rezaee3

  • 1Department of Urology, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.

Urologic oncology
|January 23, 2025
PubMed
概括

糖尿病显著增加了在尿路转移的激进囊切除术后的代谢酸风险. 甲胺的使用可能有助于,但糖尿病是主要的危险因素,特别是在大陆转移.

关键词:
膀癌是一种癌症.复杂化 复杂化 复杂化 复杂化糖尿病是一种糖尿病.代谢性亚cidosis 的发生.甲胺是一种甲胺.进行激进的囊切除术.尿路的转移 尿路的转移

更多相关视频

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

16.5K
Modified Single-Loop Reconstruction for Pancreaticoduodenectomy00:13

Modified Single-Loop Reconstruction for Pancreaticoduodenectomy

Published on: September 28, 2019

7.3K

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
173
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
148